New MaskCountTM app allows citizen scientists to contribute to effort to contain COVID-19

INDIANAPOLIS — A new app will allow anyone to contribute real-world data to the effort to understand COVID-19. “MaskCountTM,” from Regenstrief Institute, lets users document the number of people they see wearing or not-wearing masks, all without identifying anyone. This information will be combined for display and analyzed with other COVID-19 data, such as case…

Cincinnati Children’s research helps pave way for newly approved use of drug

Following two decades of research on a group of rare diseases called hypereosinophilic syndrome at Cincinnati Children’s Hospital Medical Center, the U.S. Food and Drug Administration has approved the drug Nucala (mepolizumab) for use in the treatment of patients with hypereosinophilic syndrome. Hypereosinophilic syndrome, also known as HES, is a life-threatening group of blood disorders…